IP Verse

Actelion Pharmaceuticals Us, Inc. V. Alembic Pharmaceuticals Limited - 1:23-cv-00383

Explore the details of the Actelion Pharmaceuticals Us, Inc. V. Alembic Pharmaceuticals Limited case under case number 1:23-cv-00383 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:23-cv-00383
Filing Date
Apr 4, 2023
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved in the Case

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Alembic Pharmaceuticals Limited -
Actelion Pharmaceuticals Ltd -
Nippon Shinyaku Co., Ltd. -

Patents Involved in the Case

There is a single patent involved in this case.

Application NumberPatent Number
-US7205302B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Apr 4, 2023Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Nippon Shinyaku Co., Ltd. (twk) (Entered: 04/05/2023)PACER Document
Apr 4, 2023Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc. filed by Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc. (twk) (Entered: 04/05/2023)PACER Document
Apr 4, 2023Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,205,302. (twk) (Entered: 04/05/2023)PACER Document
Apr 4, 2023Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: February 24, 2023. Date of Expiration of Patent: October 31, 2026. Thirty Month Stay Deadline: August 24, 2025. (twk) (Entered: 04/05/2023)PACER Document
Apr 4, 2023Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) (Entered: 04/05/2023)PACER Document
Apr 4, 2023COMPLAINT filed against Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4105692.) - filed by Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd, Nippon Shinyaku Co., Ltd. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(twk) (Entered: 04/05/2023)PACER Document
Apr 26, 2023WAIVER OF SERVICE returned executed by Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd, Nippon Shinyaku Co., Ltd.: For Alembic Pharmaceuticals, Inc. waiver sent on 4/13/2023, answer due 6/12/2023. (Balick, Steven) (Entered: 04/26/2023)PACER Document
Apr 26, 2023WAIVER OF SERVICE returned executed by Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd, Nippon Shinyaku Co., Ltd.: For Alembic Pharmaceuticals Limited waiver sent on 4/13/2023, answer due 6/12/2023. (Balick, Steven) (Entered: 04/26/2023)PACER Document
Jun 12, 2023STIPULATION TO EXTEND TIME for Alembic to move against, answer or otherwise plead in response to the Complaint to July 5, 2023 - filed by Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc.. (Gaza, Anne) (Entered: 06/12/2023)PACER Document
Jul 3, 2023PROPOSED CONSENT JUDGMENT AND INJUNCTION, by Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc., Nippon Shinyaku Co., Ltd.. (Balick, Steven) (Entered: 07/03/2023)PACER Document
Jul 3, 2023Letter to The Honorable Gregory B. Williams from Steven J. Balick regarding the Parties' Proposed Consent Judgment and Injunction. (Balick, Steven) (Entered: 07/03/2023)PACER Document
Jul 5, 2023Report to the Commissioner of Patents and Trademarks. (ntl) (Entered: 07/05/2023)PACER Document
Jul 5, 2023CONSENT JUDGMENT AND ORDER OF PERMANENT INJUNCTION. Signed by Judge Gregory B. Williams on 7/5/23. (ntl) (Entered: 07/05/2023)PACER Document
Apr 4, 2023No Summons Issued. (twk)PACER Document
Apr 12, 2023Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. Associated Cases: 1:23-cv-00383-GBW, 1:23-cv-00389-GBW (rjb)PACER Document
Jun 14, 2023SO ORDERED, re 9 STIPULATION TO EXTEND TIME for Alembic to move against, answer or otherwise plead in response to the Complaint to July 5, 2023 filed by Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc. Signed by Judge Gregory B. Williams on 6/14/23. (ntl)PACER Document